InflaRx NV (STU:IF0) Inventories, Other: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:IF0 InflaRx NV STU:IF0
39 GF Score
Price €1.82
! 2 Warning Signs
View Full Analysis

What is InflaRx NV Inventories, Other?

InflaRx NV STU:IF0 +0.33% 39 Inventories, Other is €0.00 Mil as of Jun. 2026. GuruFocus rates STU:IF0 with a GF Score™ of 39/100. The stock has 2 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. InflaRx NV's other inventories for the quarter that ended in Jun. 2026 was €0.00 Mil.

InflaRx NV's annual other inventories increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.00 Mil) but then declined from Dec. 2024 (€0.00 Mil) to Dec. 2025 (€0.00 Mil).

InflaRx NV Inventories, Other Historical Data

* Premium members only.

The historical data trend for InflaRx NV's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InflaRx NV Inventories, Other Chart

InflaRx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

InflaRx NV Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
STU:IF0
39GF Score
InflaRx NV STU:IF0
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of €0.00 Mil mean?
InflaRx NV (STU:IF0) has a Inventories, Other of €0.00 Mil as of Jun. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on InflaRx NV and its competitors.
Is InflaRx NV's Inventories, Other too high?
InflaRx NV's current Inventories, Other is €0.00 Mil. Overall, InflaRx NV has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's Inventories, Other compare to NWBO and PRQR?
InflaRx NV's Inventories, Other of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Biotechnology company?
A good Inventories, Other depends on the Biotechnology industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on InflaRx NV and its competitors. InflaRx NV's current Inventories, Other is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (STU:IF0) has a current Inventories, Other of €0.00 Mil. The current Inventories, Other is €0.00 Mil. InflaRx NV's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For InflaRx NV (STU:IF0), the current Inventories, Other is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InflaRx NV Business Description

Other Exchanges IFRX:USAIF0:Germany
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a German clinical-stage biopharmaceutical company that develops inhibitors of the complement activation factor C5a and its receptor C5aR to treat inflammatory and autoimmune diseases. Its lead product, vilobelimab (marketed as GOHIBIC), is an intravenously administered anti-C5a monoclonal antibody that selectively binds free C5a; it has received emergency use authorization in the United States for certain critically ill COVID-19 patients and is being studied in other indications. The company also develops izicopan, an oral small-molecule C5aR inhibitor. InflaRx conducts research and clinical development in Germany and the United States, targeting hospital and specialty care markets. As a development-stage company, it generates limited product revenue and funds operations primarily through equity financings, partnerships, and public grants rather than through broad commercial sales.
39GF Score

Get the complete analysis for STU:IF0

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.82
Price